Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Mallarkey

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Neurological Disorders|December 25, 2010
What are the Therapeutic Advances in Neurology? Opinions from World ExpertsGordon Mallarkey
Drug and Therapeutics Bulletin|March 26, 2026
Providing reliable drug information in a changing regulatory landscapeGordon Mallarkey
Drugs in Context|May 1, 2018
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbilEdgardo Kaplinsky, Gordon Mallarkey
The Journal of International Medical Research|May 17, 2022
What we are doing to help researchers publish their papers in our journalGordon Mallarkey, Matthew Thorne
Therapeutic Advances in Medical Oncology|February 17, 2017
European Society for Medical Oncology Copenhagen update: potential practice-changing findingsGordon Mallarkey, Axel Grothey
Therapeutic Advances in Medical Oncology|July 4, 2012
Pathways and biomarkers in breast cancer: latest evidenceGordon Mallarkey, R Charles Coombes
Therapeutic Advances in Medical Oncology|January 17, 2013
Targeted therapies in medical oncology: successes, failures and next stepsGordon Mallarkey, R Charles Coombes
Therapeutic Advances in Chronic Disease|December 20, 2012
Looking at the causes of, and possible treatments for, psychiatric diseases: gene-environment interactions, circadian rhythms and neuronal dysfunctionGordon Mallarkey, Philip B Mitchell
Therapeutic Advances in Musculoskeletal Disease|February 3, 2016
Osteoporosis therapeutics: recent developments at ASBMRGordon Mallarkey, David M Reid
The Medical Journal of Australia|April 21, 2009
Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory GroupDiana H Shipp, Gordon Mallarkey
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Neurological Disorders|December 25, 2010
What are the Therapeutic Advances in Neurology? Opinions from World ExpertsGordon Mallarkey
Drug and Therapeutics Bulletin|March 26, 2026
Providing reliable drug information in a changing regulatory landscapeGordon Mallarkey
Drugs in Context|May 1, 2018
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbilEdgardo Kaplinsky, Gordon Mallarkey
The Journal of International Medical Research|May 17, 2022
What we are doing to help researchers publish their papers in our journalGordon Mallarkey, Matthew Thorne
Therapeutic Advances in Medical Oncology|February 17, 2017
European Society for Medical Oncology Copenhagen update: potential practice-changing findingsGordon Mallarkey, Axel Grothey
Therapeutic Advances in Medical Oncology|July 4, 2012
Pathways and biomarkers in breast cancer: latest evidenceGordon Mallarkey, R Charles Coombes
Therapeutic Advances in Medical Oncology|January 17, 2013
Targeted therapies in medical oncology: successes, failures and next stepsGordon Mallarkey, R Charles Coombes
Therapeutic Advances in Chronic Disease|December 20, 2012
Looking at the causes of, and possible treatments for, psychiatric diseases: gene-environment interactions, circadian rhythms and neuronal dysfunctionGordon Mallarkey, Philip B Mitchell
Therapeutic Advances in Musculoskeletal Disease|February 3, 2016
Osteoporosis therapeutics: recent developments at ASBMRGordon Mallarkey, David M Reid
The Medical Journal of Australia|April 21, 2009
Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory GroupDiana H Shipp, Gordon Mallarkey
Pageof 3